The largest database of trusted experimental protocols

17 protocols using sd 208

1

Hematopoietic Stem Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
For clonogenic assays,20,000 Lin cells per condition (in triplicate) and 2000 sorted LSK cells per condition (in triplicate) were plated in Methocult GF M3434 methylcellulose (03444,Stem Cell Technologies) and cultured for 7 days. The TGFβ inhibitors such as AVID200 (Forbius), SD208 (S7071, Sigma-Aldrich) and 1D11 (Genzyme) were added in graded concentrations in the cultures. For acetaldehyde treatments, bone marrow cells were exposed to increasing doses of acetaldehyde (00070–100ML, Sigma-Aldrich) for 4 h, washed and then cultured in Methocult GF M3434 methylcellulose. The hematopoietic colonies were scored after 7 days of culture at 37 °C and 5% CO2.
For proliferation assays, sorted LSK cells were cultured in serum-free medium StemSpan SFEM (09600, StemCell Technologies) containing 1% penicillin/streptomycin (15140–122, GIBCO), 2% L-glutamine (25030–081GIBCO), 100 ng/ml TPO (315–14-10UG, Peprotech) and 100 ng/ml SCF (250–03-10UG, Peprotech). After 48 h in culture, DNA damage was assessed by immunofluorescence staining the cells to detect γH2AX foci formation (2577s, Cell Signaling) as described [13 (link)].
+ Open protocol
+ Expand
2

Cytotoxicity of Targeted Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
2D films or 3D scaffolds were seeded with tumor cells, cultured for 24 h, and then treated with 10 μM Cilengitide (Selleck Chemicals, Huston, TX, USA), 10 μM GANT 58 (Santa Cruz Biotechnology, Dallas, TX, USA), 100 nM SD208 (Sigma-Aldrich, St. Louis, MO, USA), or DMSO as a control in serum-free media. After 48 h of drug treatment, RNA was harvested for qRT-PCR analysis.
+ Open protocol
+ Expand
3

Culturing Human Cardiac Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cardiac fibroblasts (Passage number 4–6) (Cell Applications, San Diego, CA, USA) were kept in culture using DMEM High Glucose (Corning, Somerville, NY, USA) supplemented with fetal bovine serum (FBS, 10%) (Hyclone, South Logan, UT, USA), penicillin-streptomycin (P/S, 1%) (Gibco, Waltham, MA, USA), and SD208 (3 µM, TGF-β pathway inhibitor) (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C with 5% CO2. The culture was maintained with daily half-media changes until they reached approximately 80% confluency.
+ Open protocol
+ Expand
4

Stem Cell Differentiation Regulator Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant peptide and small molecules are as follows: A83-01 (Tocris 2939), Y-27632 (Enzo Life Science ALX-270-333-M005), Recombinant Mouse TGF-β 1 (Novoprotein CA59, R&D Systems 7666-MB-005), GW788388 (Sigma-SML0116-5 mg), LY-364947 (Sigma-L6293-5MG), SD-208 (Sigma-S7071-5MG), Thiazovivin (Sigma-SML1045-5 mg) and SR-3677 (Sigma-SML0774-5 mg).
+ Open protocol
+ Expand
5

Preparation and Characterization of Membrane-Coated PLGA Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
PLGA nanoparticles were prepared with o/w single emulsion. 1mL of PLGA (resomer® RG 503 H, Sigma Aldrich, USA) dissolved in dichloromethane (6 mg/ml) was added dropwise into 6ml of 0.5% PVA solution. SD-208 (Sigma Aldrich, USA) was mixed with PLGA solution with a polymer-to-drug ratio of 10:1. For the fluorescence imaging experiment, Cy5.5 NHS or DiD (Sigma Aldrich, USA) was loaded into the PLGA solution at 5% (w/w). The mixture was then agitated with 200RPM until the dichloromethane was evaporated entirely. After the dichloromethane was evaporated, the solution was centrifuged and washed twice with distilled water at 20,000 g for 20 min to remove the unloaded-free drugs or dyes Membrane-coated nanoparticles were prepared with the sonication method. In short, the cell membrane was mixed with PLGA NP with a 1:1 weight ratio (w/w) and sonicated in a water bath sonicator for 3 min. In order to remove the uncoated nanoparticles, the mixture was centrifuged at 20,000 g for 20 min.
+ Open protocol
+ Expand
6

Recombinant TGF Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant TGF (R&D) was resuspended in phosphate-buffered saline (PBS) and added to cells at the desired concentrations. LDN 193189 (LDN; Sigma), SB431542 (Sigma), and SD208 (Sigma) were reconstituted using the company directions and at the desired concentrations. These recommended concentrations of the drugs were found not to be toxic to the cells as determined by trypan blue exclusion.
+ Open protocol
+ Expand
7

Inhibition of TGF-β Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human recombinant TGF-β1 was obtained from R&D Systems (Minneapolis, MN). The TGF-β RI (TβRI) kinase inhibitor SB431542 was obtained from Millipore (Billerica, MA), and SD-208 was purchased from Sigma (St Louis, MO). The following antibodies were used in this study: anti-PPM1A, anti-MMP2, anti-MMP9, anti-Smad2, anti-Smad3, anti-phosphorylated Smad2 and anti-phosphorylated Smad3 (Cell Signaling Technology, Beverly, MA) as well as anti-E-cadherin, anti-GAPDH, anti-CK19, anti-phosphorylated Smad2/3 and anti-Vim (Santa Cruz, CA, USA). SB431542 was applied during the TGF-β1 perfusion.
+ Open protocol
+ Expand
8

Neonatal Rat Ventricular Myocyte Isolation and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neonatal rat ventricular myocytes (NRVMs) were isolated from Sprague Dawley rats (50–60 rats pooled, male and female, 1 day old), kept on ice before isolation, and isolated using previously identified method.30 NRVMs were cultured for 24 hours in growth media, rinsed, and cultured 24 hours in serum‐free media (minimum essential media (MEM), HEPES, B12, Bromodeoxyuridine (BrdU), BSA, insulin, transferrin) to prevent growth of fibroblasts. CM from fibroblasts was used to treat NRVMs for 48 hours before measuring cell size. SD208 (Sigma Aldrich S7071) was used in combination with CF CM treatment of NRVMs at 3μmol/L. The same protocol was used for insulin growth factor 1 (IGF‐1) and osteopontin treatments. IGF‐1 (R&D Systems 4326‐RG‐050) and osteopontin (R&D Systems 6359‐OP‐050) were added NRVMs in serum‐free media and cultured for 48 hours before NRVMs were trypsinized and cell size was measured by Coulter Counter.
+ Open protocol
+ Expand
9

Cardiac Fibroblast Isolation and Phenotype Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fbs from the LV were isolated by a chunk enzymatic digestion protocol as described before20 (link). After first passage, Fbs were seeded at a density of 3000 cells/cm2 and cultured in DMEM (ThermoFisher) medium with 10% foetal bovine serum (FBS) and 1% of penicillin/streptomycin (Invitrogen). To induce specific Fb phenotypes, cells were either treated for 6 days with recombinant human TGF-β1 (400 pmol/L; PeproTech) or with SD-208 (3 μmol/L; Sigma-Aldrich), a specific TGF-β-receptor-I (TGF-β-RI) kinase inhibitor to respectively promote and suppress differentiation. After 6 days, the phenotype was assessed by protein expression and morphology, and functionally as the capacity for proliferation, migration, and contraction of a floating gel. These pre-treated Fbs and MyoFbs were then processed for co-culture with freshly isolated CMs. The supplemental material and Figures S1 detail the preparation and properties of the fibroblastic cells and the subsequent setup of the co-cultures.
+ Open protocol
+ Expand
10

Prostate Cancer Cell Line Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC-3, DU-145 and RM-1 prostate cancer cells were obtained from the American Type Culture Collection. The cancer cells were cultured in RPMI 1640 supplemented with 10% FBS. DTX (MedChemExpress, Monmouth Junction, New Jersey, USA), which promotes microtubule stabilization and inhibits the mitosis of cancer cells; cisplatin (MedChemExpress), a replicative polymerase inhibitor, were used at concentrations of 0, 25, 50, 100 nM and 0, 10, 20, 30 µM, respectively. Paclitaxel (PTX, MedChemExpress), was used at concentration of 200 nM. Additionally, indicated concentrations of the ATM inhibitor KU55933 (Sigma-Aldrich, St. Louis, Missouri, USA) or the NEMO binding peptide (NBD) (Enzo Biochem, New York, USA) were added at 60 min before the induction of PD-L1. For inhibitor screening, S3I-201(100 µM), Fludarabine (10 µM), UO126-EtOH (10 µM), Bay11-7082 (10 µM), JSH-23 (5 µM), SD-208 (2 µM) which obtained from Sigma-Aldrich were added and the cells were collected after 6 hours.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!